TB Alliance

(Jacquelyn Martin/AP) The Food and Drug Administration on Wednesday approved a new drug for highly drug-resistant tuberculosis, the world’s leading infectious cause of death. Tuberculosis kills 1.6 million people a year, about 500,000 of whom suffer from drug-resistant strains of the disease. The antibiotic, called pretomanid, was developed by a nonprofit group called TB Alliance …